Galactorrhea with aripiprazole [3]

Psychotherapy and Psychosomatics

Volumn 74, Issue 6, 2005, Pages 391-392

  Ruffatti, Anselmo ^a   Minervini, Lina ^a   Romano, Maria ^a   Sonino, Nicoletta ^a,b  

^a Department of Mental Health ^*  (Italy)

^b UNIVERSITY OF PADOVA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ARIPIPRAZOLE; BIPERIDEN; HALOPERIDOL; PROLACTIN; RISPERIDONE; VALPROIC ACID; NEUROLEPTIC AGENT; PIPERAZINE DERIVATIVE; QUINOLONE DERIVATIVE;

ADULT; AMENORRHEA; BREAST TENDERNESS; CASE REPORT; DOSE RESPONSE; FEMALE; GALACTORRHEA; HUMAN; LETTER; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROLACTIN BLOOD LEVEL; SCHIZOAFFECTIVE PSYCHOSIS; CHEMICALLY INDUCED DISORDER; PSYCHOSIS;

ADULT; ANTIPSYCHOTIC AGENTS; FEMALE; GALACTORRHEA; HUMANS; PIPERAZINES; PSYCHOTIC DISORDERS; QUINOLONES;

EID: 27144483015     PISSN: 00333190     EISSN: None     Source Type: Journal    
DOI: 10.1159/000087790     Document Type: Letter

References (4)

1. Lieberman JA: Dopamine partial agonists: a new class of antipsychotic. CNS Drugs 2004;18:251-267.
2. Swainston Harrison T, Perry CM: Aripiprazole: a review of its use in schizophrenia and schizoaffective disorder. Drugs 2004;64:1715-1736.
3. Marder SR, McQuade RD, Stock E, Kaplita S, Marcus R, Safferman AZ, Saha A, Ali M, Iwamoto T: Aripiprazole in the treatment of schizophrenia: safety and tolerability in short-term, placebo controlled trials. Schizophrenia Res 2003;61:123-136.
4. Mendhekar DN, Andrade C: Galactorrhea with aripiprazole. Can J Psychiatry 2005;50:243.